瑞士制药公司成为尼日利亚第一家在美援署支持下获得世卫组织硫酸锌和硫酸盐-苯丙胺药片资格预审的公司。 Swiss Pharma becomes first Nigerian company to receive WHO prequalification for Zinc Sulphate and Sulfadoxine-Pyrimethamine tablets, supported by USAID.

美援署和瑞士制药公司(Swipha)在西非制药业取得了里程碑式的成就。 USAID and Swiss Pharma (Swipha) have achieved a milestone in West Africa's pharmaceutical industry. Swipha成为尼日利亚第一家获得世卫组织两份基本药品Zinc硫酸盐和Sulfadoxine-Pyrimethamin药片资格预审的尼日利亚公司。 Swipha became the first Nigerian company to receive WHO prequalification for two essential medicines, Zinc Sulphate and Sulfadoxine-Pyrimethamine tablets. 这项成就得到美援署的支持,有助于改善该区域获得救生药品的机会,使斯维法能够在全球提供基本药品,促进儿童保健和孕产妇护理。 This achievement, supported by USAID, helps improve access to life-saving medicines in the region, enabling Swipha to supply essential medicines globally and contribute to child health and maternal care.